Our strategy Our current strategic period started in 2021, setting out our vision and goals to achieve testing for healthy and safe lives.
G20 engagement We are highlighting the importance of diagnostics in ensuring that the G20 health priorities are achieved.
Commitment tracker An open platform for the global health community to share and track commitments that will support Member States in implementing the WHA Resolution on diagnostics.
100 Days Mission A plan for the world to be able to respond to and extinguish the global threat of the next Disease X within 100 days of WHO declaring a major outbreak or pandemic.
TESTED An exhibition about medical diagnosis, and why it matters that half the world has no access to testing.
Diagnostics & disease elimination Elimination of a disease as a public health problem refers to the reduction of the incidence or prevalence of a particular disease.
FIND hails the Kingdom of Saudi Arabia on the new 10KSA “Together for Health” cancer prevention campaign FIND today congratulated the Kingdom of Saudi Arabia (KSA) on the launch of its 10KSA “Together for Health” campaign and highlighted the exceptional leadership of Her Royal Highness Princess Reema bint Bandar bin Sultan Al Saud and His Excellency Fahd bin Abdurrahman Al-Jalajel, Minister of Health, in advancing cancer prevention, early screening, and community awareness across the Kingdom.
DxConnect DxConnect is hosted by FIND, to overcome diagnostic gaps by connecting stakeholders and enabling interactions.
Data for decisions Diagnostics provide critical information for healthcare professionals, decision-makers, and people living with diseases and health conditions.
The diagnostic journey From R&D to implementation, the diagnostic value chain can be thought of as a journey of interconnected steps, or a "virtuous cycle".
WHA Resolution on strengthening diagnostics capacity The Lancet Commission on diagnostics was published in 2021, putting forward recommendations to accelerate and transform access to diagnostics globally.
FIND hails the Kingdom of Saudi Arabia on the new 10KSA “Together for Health” cancer prevention campaign FIND today congratulated the Kingdom of Saudi Arabia (KSA) on the launch of its 10KSA “Together for Health” campaign and highlighted the exceptional leadership of Her Royal Highness Princess Reema bint Bandar bin Sultan Al Saud and His Excellency Fahd bin Abdurrahman Al-Jalajel, Minister of Health, in advancing cancer prevention, early screening, and community awareness across the Kingdom. FIND 09 Dec 2025
منظمة فايند (FIND) تشيد بجهود المملكة العربية السعودية في إطلاق حملة “10KSA: معاً للصحة” للوقاية من السرطان هنأت منظمة فايند (FIND) اليوم المملكة العربية السعودية بمناسبة إطلاق حملة "10KSA: معاً للصحة"، مشيدةً بالقيادة الاستثنائية لصاحبة السمو الملكي الأميرة ريما بنت بندر بن سلطان آل سعود، ومعالي وزير الصحة الأستاذ فهد بن عبد الرحمن الجلاجل، لجهودهما في تعزيز الوقاية من السرطان، وتوسيع نطاق الكشف المبكر، ورفع مستوى الوعي المجتمعي في جميع أنحاء المملكة. FIND 09 Dec 2025
FIND and Vietnam’s Hai Phong Department of Health Launch Project to Accelerate Cervical Cancer Testing 04 Nov 2025
FIND appoints Henri Mwaniki as Chief Financial Officer The FIND Board are pleased to have appointed Mr Henri Mwaniki as the Chief Financing Officer (CFO) and will take over the functions of Chief Operations Officer in accordance with FIND’s statutes and by-laws. FIND 12 Sep 2025
Dr. Ifedayo Adetifa on NTDs, Cervical Cancer & Africa’s Pandemic Preparedness Adonis Byemelwa 17 Feb 2025
Diagnostics & the Nagoya Protocol The Nagoya protocol is an international agreement, supplementary to the United Nations Convention on Biological Diversity.
Diagnostics & disease elimination Elimination of a disease as a public health problem refers to the reduction of the incidence or prevalence of a particular disease or infection in a defined geographic area, as a result of deliberate efforts.
Diagnostics & trade finance Trade finance is a term that describes the financial instruments and products used by companies to facilitate international trade and commerce.
Diagnostics & intellectual property The pharmaceutical and vaccine industries both make regular use of patents to protect their innovative products. The situation for diagnostics is less straightforward; in many cases, patents are less consequential for diagnostics than for other health products.
Diagnostics & vaccines The benefits of vaccines are well known. However, vaccines cannot be developed, tested, targeted, or used efficiently and effectively without diagnostics. This document explains how diagnostics are a critical enabler for vaccines.
